eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
Original paper

Plasma leukocyte-derived extracellular vesicles are related to target vessel revascularization in off-pump coronary artery bypass grafting

Tomasz K. Urbanowicz
1
,
Aleksandra Gąsecka
2
,
Anna Olasińska-Wiśniewska
1
,
Michał Michalak
3
,
Michał Rodzki
1
,
Ewelina Błażejowska
2
,
Krzysztof J. Filipiak
4, 5
,
Mariusz Kowalewski
6, 7
,
Andrzej Tykarski
5
,
Marek Jemielity
1

  1. Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, Poznan, Poland
  2. 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
  3. Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland
  4. Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
  5. Department of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
  6. Department of Cardiac Surgery, Center of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland
  7. Department of Cardiothoracic Surgery, Heart and Vascular Center, Maastricht University Medical Centre (MUMC), Maastricht, the Netherlands
Adv Interv Cardiol
Online publish date: 2024/12/02
Article file
- plasma leukocyte.pdf  [0.16 MB]
Get citation
 
 
1. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e4-e17.
2. Maron DJ, Hochman JS, Reynolds HR, et al.; ISCHEMIA Research Group. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 2020; 382: 1395-407.
3. Doenst T, Schneider U, Can T, et al. Cardiac surgery 2021 reviewed. Thorac Cardiovasc Surg 2022; 70: 278-88.
4. Schmidt AF, Haitjema S, Sartipy U, et al. Unravelling the difference between men and women in post-CABG survival. Front Cardiovasc Med 2022; 9: 768972.
5. Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Gender differences in coronary artery diameters and survival results after off-pump coronary artery bypass (OPCAB) procedures. J Thorac Dis 2021; 13: 2867-73.
6. Duggan JP, Peters AS, Trachiotis GD, Antevil JL. Epidemiology of coronary artery disease. Surg Clin North Am 2022; 102: 499-516.
7. Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, et al. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci 2021; 22: 3850.
8. Grajek S, Michalak M, Urbanowicz T, Olasińska-Wiśniewska A. A meta-analysis evaluating the colchicine therapy in patients with coronary artery disease. Front Cardiovasc Med 2021; 8: 740896.
9. Błażejowska E, Urbanowicz T, Gąsecka A, et al. Diagnostic and prognostic value of miRNAs after coronary artery bypass grafting: a review. Biology (Basel) 2021; 10: 1350.
10. Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010; 36: 907-16.
11. Pirro M, Schillaci G, Paltriccia R, et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006; 26: 2530-5.
12. Reddel CJ, Pennings GJ, Lau JK, et al. Circulating platelet-derived extracellular vesicles are decreased after remote ischemic preconditioning in patients with coronary disease: a randomized controlled trial. J Thromb Haemost. 2021; 19: 2605-11.
13. Harky A, Sankaranarayanan V, Kong QG. Internal mammary artery: the primary conduit for surgical revascularization. Coron Artery Dis 2021; 32: 64-72.
14. Tadokoro N, Fukushima S, Minami K, et al. 15-year outcomes of the JOCRI study (JOCRIED study): a randomised comparison of off-pump and on-pump multiple arterial coronary revascularisation. Gen Thorac Cardiovasc Surg 2023; 71: 151-7.
15. Jegaden OJL, Farhat F, Jegaden MPO, et al. How decisive is the number of distal arterial anastomoses in coronary bypass surgery? J Cardiothorac Surg 2021; 16: 6-17.
16. Farouk A, Hamed RA, Elsawy S, et al. Measuring the systemic inflammatory response to on- and off-pump coronary artery bypass graft (CABG) surgeries using the tryptophan/kynurenine pathway. J Invest Surg 2022; 35: 1621-5.
17. Ladak SS, McQueen LW, Layton GR, et al. The role of endothelial cells in the onset, development and modulation of vein graft disease. Cells 2022; 11: 3066.
18. Urbanowicz T, Olasińska-Wiśniewska A, Michalak M, et al. Pre-operative systemic inflammatory response index influences long-term survival rate in off-pump surgical revascularization. PLoS One 2022; 17: e0276138.
19. Durk-Kozica M, Wróbel Am Platt M, Stepień E. Comparison of qNANO results from the isolation of extracellular microvesicles with the theoretical model. Bio-Algorithms and Med-Systems 2022; 18: 171-9.
20. Welsh JA, Goberdhan DCI, O’Driscoll L, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 2024; 13: e12404.
21. Stępień EŁ, Durak-Kozica M, Moskal P. Extracellular vesicles in vascular pathophysiology: beyond their molecular content. Pol Arch Intern Med 2023; 133: 16483-90.
22. Magouliotis DE, Fergadi MP, Zotos PA, et al. Differences in long-term survival outcomes after coronary artery bypass grafting using single vs multiple arterial grafts: a meta-analysis with reconstructed time-to-event data and subgroup analyses. Gen Thorac Cardiovasc Surg 2023; 71: 77-89.
23. Aboul-Hassan SS, Stankowski T, Perek B, et al. Coronary artery bypass surgery: comparing the long-term impact of total arterial grafting with multiarterial plus saphenous vein grafting. J Surg Res 2023; 290: 276-84.
24. Xenogiannis I, Zenati M, Bhatt DL, et al. Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies. Circulation 2021; 144: 728-45.
25. Caliskan E, de Souza DR, Böning A, et al. Saphenous vein grafts in contemporary coronary artery bypass graft surgery. Nat Rev Cardiol 2020; 17: 155-69.
26. Brown PA, Brown PD. Extracellular vesicles and atherosclerotic peripheral arterial disease. Cardiovasc Pathol 2023; 63: 107510.
27. D’Ascenzo F, Femminò S, Ravera F, et al. Extracellular vesicles from patients with acute coronary syndrome impact on ischemia-reperfusion injury. Pharmacol Res 2021; 170: 105715.
28. Abel F, Giebel B, Frey UH. Agony of choice: how anesthetics affect the composition and function of extracellular vesicles. Adv Drug Deliv Rev 2021; 175: 113813.
29. McVey MJ, Kuebler WM. Extracellular vesicles: biomarkers and regulators of vascular function during extracorporeal circulation. Oncotarget 2018; 9: 37229-51.
30. Meyer AD, Gelfond JA, Wiles AA, et al. Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems. ASAIO J 2015; 61: 37-42.
31. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003; 21: 107-37.
32. Zhuang L, Wang Y, Chen Z, et al. Global characteristics and dynamics of single immune cells after myocardial infarction. J Am Heart Assoc 2022; 11: e027228.
33. Wang SM, Liu GQ, Xian HB, et al. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-B signaling pathway. Eur Rev Med Pharmacol Sci 2019; 23: 4898-907.
34. Martini E, Kunderfranco P, Peano C, et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation 2019; 140: 2089-107.
35. Eyileten C, Jakubik D, Shahzadi A, et al. Diagnostic performance of circulating miRNAs and extracellular vesicles in acute ischemic stroke. Int J Mol Sci 2022; 23: 4530.
36. Serrano CV Jr, Souza JA, Lopes NH, et al. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective randomized study. J Crit Care 2010; 25: 305-12.
37. Laurikka A, Vuolteenaho K, Toikkanen V, et al. Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study. Cells 2022; 11: 3378.
38. Malik V, Kale SC, Chowdhury UK, et al. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring heart-type fatty-acid-binding protein release. Tex Heart Inst J 2006; 33: 321-7.
39. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res 2012; 110: 356-69.
40. Núñez J, Sanchis J, Bodí V, et al. Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes. Eur J Intern Med 2009; 20: 768-74.
41. Aung HH, Tung JP, Dean MM, et al. Procoagulant role of microparticles in routine storage of packed red blood cells: potential risk for prothrombotic post-transfusion complications. Pathology 2017; 49: 62-9.
42. Papp J, Toth A, Sandor B, et al. The influence of on-pump and off-pump coronary artery bypass grafting on hemorheological parameters. Clin Hemorheol Microcirc 2011; 49: 331-46.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.